8348 Auer et al.
Macromolecules, Vol. 36, No. 22, 2003
Resu lts a n d Discu ssion
-CH2CH2--); 2.1, 2.12, 2.15 (3S, 9H, ArCH3); 2.62 (t, 2H, CH2-
Ar); 4.23 (s, 1H,OH); 4.8-5.0 (m 2H, dCH2); 5.7-5.9 (m,1H,
dCH). 13C NMR (CDCl3, δ): 11.3, 11.8, 12.2, 20.7, 23.6, 28.0,
31.7, 38.7, 74.1, 76.7, 77.0, 77.3, 114.2, 117.1, 118.5, 139.1,
144.7, 145.4.
Syn th etic Rou tes to Vita m in E Mon om er s. The
structure of natural vitamin E is essentially based on a
chroman skeleton having a phytyl chain attached to it
containing three chiral carbons atoms on the 2, 4′, and
8′ positions. The high antioxidant activity of R-toco-
pherol has been attributed to stereoelectronic effects
exerted by the chroman structure. Hence, its two-ring
structure gives additional stability to the tocopheroxyl
radical through interaction of the orbital overlap be-
tween the p-type lone pair orbital of the oxygen para to
the -OH group and the semioccupied molecular orbital
of the tocopheroxyl radical. Thus, the chroman structure
is responsible for the intrinsic antioxidant activity of
vitamin E, while the long side chain only acts to enhance
the solubility of the polymer.14 Therefore, in the present
work, our primary synthetic strategy to produce poly-
merizable vitamin E derivatives was to preserve the
chromanol moiety and replace the long phytyl side chain
moiety with an R-alkenyl group at the 2 position. To
the best of our knowledge, the number of R-tocopherol
compounds having a polymerizable alkenyl group in the
2, 3, 4, 5, 7, or 8 position are unprecendented in the
literature. However, in previous studies a large number
of other model compounds of R-tocopherol have been
synthesized such as 6-hydroxyl-2,2,5,7,8-pentamethyl-
chroman, 6-hydroxyl-2,5-dimethyl-2-phytylbenzo[7,8]-
chroman,15 2,3-dihydroxy-2,2,4,6,7-pentamethylbenzo-
furan,16 and 6-hydroxylthiochroman17 derivatives. The
first model compounds of R-tocopherol were prepared
by Smith, Kareer, and Bergel already during late 1930
by condensation of trimethylhydroquinone (TMHQ) with
isophytol in the presence of various catalyst systems.18
During the following years, mainly modifications of
this process in terms of solvents and catalyst systems,
e.g., Lewis or Brønsted acids, were developed.19 Using
the same approach, we started to investigate synthetic
procedures to polymerizable hydroxylchromans. First,
we synthesized 3-methylhept-1,6-dien-3-ol due to the
fact that it contains an R-olefinic moiety and is other-
wise an analogous reagent to the first isoprenol unit of
isophytol. The condensation of TMHQ with 3-methyl-
hept-1,6-dien-3-ol in refluxing formic acid afforded 1 as
a slightly yellow liquid with a boiling point of 151 °C, 1
mmHg, in a moderate yield (54% yield). Thus, this
synthetic pathway depicted in Scheme 1a to polymer-
izable tocopherol derivatives could be of both industrial
and academic interest. As anticipated, the normal
condensation routes of TMQH with 3-methylhept-1,6-
dien-3-ol using either ZnCl2/HCl or AlCl3/CH3NO2 were
not convenient, due to the fact that the R-olefinic double
bond was chlorinated.20
P r ep a r a tion of 6-Allyl-7-h yd r oxy-2,2,8,9-tetr a m eth yl-
ch r om a n (3). 6-Hydroxy-2,2,7,8-tetramethylchroman (3.0 g,
11.5 mmol; synthesized according to the procedure described
in the literature13) was diluted in acetone, and then K2CO3
(1.60 g, 11.5 mmol) was added gradually. Then the reaction
mixture was allowed to react for 30 min followed by dropwise
addition of allyl bromide (1.40 g, 11.6 mmol). Finally, the
solvent was removed, the residue was taken up in diethyl ether
and washed with water, and the organic phase was dried over
sodium sulfate. After removal of solvent, allylchromanoxy
ether was obtained (2.55 g, 85 yield %). The produced allyl-
chromanoxy ether was dissolved in DMF and heated to 155
°C, whereby via Claisen rearrangement, crude 3 was obtained.
After distillation 2.3 g of 3 (bp 120 °C/0.1 mmHg) was obtained
as a slightly yellow liquid. MS: m/e (rel intens) M+ 246 (47),
190 (34), 175 (23), 149 (10), 127 (6), 113 (10), 97 (15), 85 (47),
71 (69), 57 (100). 1H NMR (CDCl3, δ): 1.25, 1.28 (2s, 6H,
-CH3); 1.77 (2s, 4H, CH2); 2.11, 2.15 (2s, 6H, ArCH3); 2.66
(m, 2H, -CH2); 3.36-3.38 (m, 3H, CH2CHd); 4.40 (s, 1H, OH);
5.01-5.08 (m, 2H, dCH2), 5.9-6.0 (m, 1H, dCH,). 13C NMR
(CDCl3, δ): 11.9, 12.1, 14.1, 20.5, 22.7, 26.7, 29.7, 30.5, 31.9,
33.1, 72.5, 115.4, 116.8, 120.0, 122.1, 123.8, 135.9, 145.1, 145.9.
P r ep a r a tion of 4-Meth ylen e-(3,5-d i-ter t-bu tyl-4-p h en -
oxy)styr en e (4). To a solution of 2,6-di-tert-butylphenol (103
g, 0.5 mol) in 300 mL of methanol was added dropwise a
solution of KOH (32.74 g, 0.57 mol) in 200 mL of methanol.
The mixture was stirred overnight, giving a potassium salt of
the phenolic derivative. The methanol was evaporated, leaving
a green powdery residue. The residue was dissolved in 500
mL of dimethylformamide (DMF), then vinylbenzyl chloride
(91.5 g, 0.6mol) was added dropwise under agitation followed
by addition of tetrabutylammonium bromide (1.6 g, 5.0 mmol),
and the temperature was raised to 100 °C. After 12 h the
solvent was evaporated, and the remaining residue was
suspended in Et2O and filtered through brine. Then, the
solvent was evaporated, and the unreacted vinylbenzyl chlo-
ride and 2,6-di-tert-butylphenol were removed by distillation
under reduced pressure. The residue was recrystallized four
times from acetone to afford 9.82 g (6% yield) of 4 with a
melting point of 129-131 °C. MS: m/e (rel intens) M+ 322 (44),
307 (100), 265 (8), 139 (4), 117 (43), 91 (4), 57 (5). 1H NMR
(CDCl3, δ): 1.40 (s, 18H, C(CH3)3), 3.88 (s, 2H, CH2), 5.05 (s,
1H, OH), 5.19 (dd, 1H, J ) 10.9, 1.0 Hz, dCH2), 5.70 (dd, 1H,
J ) 17.6, 1.0 Hz, dCH2), 6.69 (dd, 1H, J ) 17.6, 10.9 Hz, CHd
CH2), 6.98 (s, 2H, Ar), 7.16 (d, 2H, J ) 8.1 Hz, Ar), 7.33 (dt,
2H, J ) 8.1, 1.7 Hz, Ar). 13C NMR (CDCl3, δ): 30.29, 34.27,
41.54, 112.94, 125.39, 126.21, 128.95, 131.40, 135.20, 135.82,
136.69, 141.56, 152.05.
P r ep a r a t ion of 4-Met h ylen e-(3,5-d i-ter t-b u t yl-4-t r i-
m eth ylsiloxyp h en yl)styr en e (5). To a solution of 4 (0.50 g,
1,55 mmol) in 3 mL of THF was added dropwise a solution of
BuLi (2.5 M in hexanes, 0.62 mL) at -80 °C, and the reaction
mixture was stirred for 10 min. Chlorotrimethylsilane (0.40
mL, 3.10 mmol) was then slowly added to the reaction mixture,
and stirring was continued for 30 min at -80 °C and 1 h at 0
°C. The solution was neutralized with water (5 mL), hexane
(50 mL) was added, and the organic phase was washed with
water (50 mL), dried over sodium sulfate, filtered, and
concentrated under reduced pressure. Chromatography of the
residue with hexane afforded 5 (570 mg, 93%) as a white solid,
mp 48 °C. MS: m/e (rel intens): M+ 394 (39), 379 (43), 323
(5), 305 (4), 117 (61), 73 (100), 57 (16). 1H NMR (CDCl3, δ):
0.38 (s, 9H, Si(CH3)3), 1.35 (s, 18H, C(CH3)3), 3.86 (s, 2H, CH2),
5.18 (dd, 1H, J ) 10.9, 1.0 Hz, dCH2), 5.69 (dd, 1H, J ) 17.6,
1.0 Hz, dCH2), 6.68 (dd, 1H, J ) 17.6, 10.9 Hz, CHdCH2),
7.03 (s, 2H, Ar), 7.14 (d, 2H, J ) 8.0 Hz, Ar), 7.32 (d, 2H, J )
8.0 Hz, Ar). 13C NMR (CDCl3, δ): 3.93, 31.24, 35.05, 41.34,
112.90, 126.18, 126.20, 129.01, 132.07, 135.17, 136.72, 140.50,
141.52, 151.38.
In recent years there has been a continuous search
for vitamin E analogues with enhanced antioxidant
activity. The most notable improvements in antioxidant
activity have been measured for the class of five-
membered heterocyclic ring analogues such as 2,3-
dihydroxybenzofuran and for the R-naphthofuran class
of derivatives such as 6-hydroxy-2,5-dimethyl-2-phytyl-
7,8-benzochroman, which exhibit higher kinh values 1.8-
10 times that of R-tocopherol.21 This encouraged us to
try to develop a one-step synthetic route to 2 from cheap
starting materials, i.e., TMHQ and a mixture of cis/
trans-2,7-octadien-1-ol, as illustrated in Scheme 1b.
However, despite numerous modifications of the reac-
tion conditions, the result was always a complex reac-
tion mixture.22 This is in accordance with the results